|
Volumn 24, Issue 1, 2013, Pages 7-9
|
BCL-2: A New Therapeutic Target in Estrogen Receptor-Positive Breast Cancer?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE;
4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE;
ABT 199;
ANTINEOPLASTIC AGENT;
AZD 8055;
BIM PROTEIN;
FULVESTRANT;
PROTEIN BAD;
PROTEIN BAK;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN BCL W;
PROTEIN BCL XL;
PROTEIN NOXA;
PUMA PROTEIN;
TAMOXIFEN;
UNCLASSIFIED DRUG;
BREAST EPITHELIUM;
CANCER CELL;
CANCER HORMONE THERAPY;
CELL PROLIFERATION;
CELL SURVIVAL;
COMBINATION CHEMOTHERAPY;
ENDOMETRIUM HYPERPLASIA;
ESTROGEN RECEPTOR POSITIVE BREAST CANCER;
GENE EXPRESSION PROFILING;
GENETIC TRANSCRIPTION;
HUMAN;
MONOTHERAPY;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN TARGETING;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
TREATMENT RESPONSE;
|
EID: 84880005462
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2013.06.006 Document Type: Short Survey |
Times cited : (35)
|
References (10)
|